S&P 500 5,235.18 +1.02%EUR/USD 1.0840 +0.21%GBP/USD 1.2710 +0.14%USD/JPY 149.50 −0.18%BRENT $82.40 −0.81%BTC $67,800 −0.21%GOLD $2,341 +0.55%NASDAQ 16,420.55 +0.74%S&P 500 5,235.18 +1.02%EUR/USD 1.0840 +0.21%GBP/USD 1.2710 +0.14%USD/JPY 149.50 −0.18%BRENT $82.40 −0.81%BTC $67,800 −0.21%GOLD $2,341 +0.55%NASDAQ 16,420.55 +0.74%
A daily business newspaper · Founded in 2026

Money Talk

Finance and markets: business, quotes, gold, energy and releases.

Rosen Law Firm Targets Gildan Activewear Over Misleading Disclosure Claims

A sharp 18.7% plunge in Gildan Activewear shares on June 16, 2026, has triggered a formal investigation by Rosen Law Firm. The legal action centers on allegations that the apparel manufacturer obscured negative organic growth through aggressive financial engineering, potentially misleading shareholders about the company’s true financial health.

Rosen Law Firm Targets Gildan Activewear Over Misleading Disclosure Claims
Photo: Bio & News

The investigation follows a report from Jehoshaphat Research, which disclosed a short position in the Canadian firm. Analysts at the research house argued that Gildan Activewear’s revenue growth figures were illusory, masking a long-term decline in core business performance. Following the release of these findings, the stock price suffered a significant correction, prompting the New York-based law firm to seek potential class action status for affected investors.

Rosen Law Firm is currently soliciting participants for a prospective lawsuit, operating on a contingency fee basis. Investors who purchased securities during the period in question are encouraged to contact attorney Phillip Kim to review their eligibility for recovery. The firm asserts that its practice, which has previously secured hundreds of millions of dollars in settlements, provides the necessary resources to challenge the company’s leadership regarding these disclosure practices.

Share article
TelegramXFacebook

When reusing this material a link to Money Talk is required.

Comments (0)

Leave a comment

No comments yet. Be the first!